Health
EHR data support reported effectiveness of Ad26.COV2.S vaccine – Medical Xpress
The effectiveness of the Johnson & Johnson Ad26.COV2.S vaccine is 73.6 percent for preventing severe acute respiratory syndrome…
The effectiveness of the Johnson & Johnson Ad26.COV2.S vaccine is 73.6 percent for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study published online Nov. 2 in JAMA Network Open.
Juan Corchado-Garcia,…
Continue Reading
-
Noosa News7 hours agoPill checking to resume in Queensland months after government axed funding
-
General20 hours agoAs Iran-Australia relations plunge to a new low, Tehran faces another diplomatic setback
-
Noosa News16 hours agoBrisbane nation’s third-youngest capital; Leaders condemn anti-immigration rally
-
Business9 hours agoWhy Lynas, Mesoblast, PEXA, and Sayona Mining shares are tumbling today